Clinical Trial Results:
A double blind, double dummy, randomised, multicentre, two arm parallel group study to assess the efficacy and safety of FlutiForm® pMDI 125/5 µg (2 puffs bid) vs Symbicort® Turbohaler® 200/6 µg (2 puffs bid) in adolescent and adult subjects with moderate to severe persistent, reversible asthma.
Summary
|
|
EudraCT number |
2009-017223-25 |
Trial protocol |
PL HU BG |
Global completion date |
30 Oct 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v3(current) |
This version publication date |
06 Apr 2016
|
First version publication date |
23 May 2015
|
Other versions |
v1 , v2 |
Version creation reason |
|
Summary report(s) |
FLT3507 synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.